Werewolf Therapeutics, Inc. (HOWL)
NASDAQ·Healthcare·Biotechnology
$1.02
+0.75%
Mkt Cap $47.63M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$6.50
Range $1.00 – $12.00
Implied Upside
+538.8%
Consensus $6.50 vs current $1.02
NASDAQ·Healthcare·Biotechnology
$1.02
+0.75%
Mkt Cap $47.63M
No recent rating data.
Price Target (2 analysts)
$6.50
Range $1.00 – $12.00
+538.8%
Consensus $6.50 vs current $1.02